Curiox Biosystems Names Shanin Barican VP of Business Development

By Public Technologies
  • Curiox Biosystems appointed Shanin Barican vice president of business development and Kristine Friscino vice president of marketing.
  • Barican previously served as senior director of business development at Opentrons Labworks.
  • Friscino most recently served as vice president of marketing and product at Nuclera.
  • Elizabeth Woo, formerly Thermo Fisher Scientific’s vice president of cell, gene and advanced therapies, joined the newly formed Strategic Advisory Board.
  • David Newble, who previously led TAP Biosystems and SPT Labtech, also joined the advisory board to guide adoption and commercial expansion.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Curiox Biosystems Co., Ltd. published the original content used to generate this news brief via Business Wire (Ref. ID: 202610291000BIZWIRE_USPR_____20261029_BW482791) on October 29, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk